Table: Hisamitsu - 9-MTH group results

Hisamitsu Pharmaceutical Co

09/01/2025 06:30

Jan 9 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2024        Nov 30, 2023     Feb 28, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              111.25              102.83           154.00    
                   (+8.2 pct)          (+11.9 pct)      (+8.7 pct)  
  Operating           13.22               12.25            18.00    
                   (+8.0 pct)          (+44.0 pct)      (+36.7 pct) 
  Recurring           16.47               16.64            23.00    
                   (-1.0 pct)          (+28.0 pct)      (+17.1 pct) 
  Net                 13.66               12.09            20.50    
                   (+13.0 pct)         (+27.0 pct)      (+46.7 pct) 
  EPS              185.02 yen          156.41 yen       277.66 yen  
  EPS Diluted      184.76 yen          156.25 yen                   
  Ann Div                               85.00 yen        90.00 yen  
  -Q2 div           45.00 yen           42.50 yen                   
  -Q4 div                               42.50 yen        45.00 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T